share_log

リボミック:umedaptanib pegol(抗FGF2アプタマー)に関する用途特許の台湾における特許査定のお知らせ

Ribomic: Notice of patent assessment in Taiwan for application patents relating to umedaptanib pegol (anti-FGF2 aptamer)

JPX ·  Nov 19, 2024 14:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more